BRK-B vs FBP
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
FBP presents a stark contrast between strong profitability and deteriorating operational health, highlighted by a weak Piotroski F-Score of 2/9. While the company maintains a robust ROE of 19.04% and a consistent track record of earnings beats, the low health score and bearish insider sentiment suggest underlying systemic risks. The stock is currently trading slightly below its Graham Number ($24.73), suggesting a defensive value floor, though it remains far below its growth-based intrinsic value of $63.42. Overall, the strong earnings momentum is offset by poor deterministic health metrics and negative insider signals.
Compare Another Pair
Related Comparisons
BRK-B vs FBP: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and First BanCorp. (FBP) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.